announces

  1. T

    Mayo Clinic Announces Collaboration To Provide Health Information In Spanish At Viday

    VidaySalud.com, a Spanish-language website for consumer health information, has announced a collaboration with Mayo Clinic to bring medical expertise to Hispanic audiences in the U.S. and worldwide. Doctors and researchers at Mayo Clinic will work with VidaySalud.com and its founder, Aliza...
  2. V

    Mazda Announces Plans For 2011 Geneva Auto Show

    While Acura has already announced part of its 2011 Chicago Auto Show lineup, Mazda has skipped ahead to its Geneva Show plans. When the world’s media descends on Switzerland for press days on March 1 and 2, Mazda will be treating them to a new concept titled MINAGI, as well as the Zoom-Zoom...
  3. G

    Sony announces Next Generation Portable Entertainment System and Android

    Company announces new portable gaming hardware and PlayStation Suite, delivering PlayStation games to Android devices.
  4. T

    World Bank Announces Additional $5M Grant To Fight Cholera In Haiti

    The World Bank on Tuesday "announced a $15 million grant to Haiti to fight a persistent cholera epidemic," SAPA/Health24 reports. In a press release, the bank said it approved an additional $5 million to be added to a previously announced $10 million grant. "The funds, said the organisation in...
  5. G

    Microsoft announces support of System on a Chip from Intel, AMD, and ARM for next ver

    Microsoft demonstrated the next version of Windows running on new SoC platforms from Intel running on x86 architecture and from NVIDIA, Qualcomm and Texas Instruments on ARM architecture.
  6. T

    American Society Of Hematology Announces 2011 Scholar Award Winners

    The American Society of Hematology (ASH) announces the 2011 Scholar Award recipients. The program is designed to support hematologists who have chosen a career in research by providing partial salary or other support during the critical period required for completion of training and achievement...
  7. T

    Vicus Therapeutics Announces Initiation Of Phase 2 Trial To Evaluate VT-122 In Patien

    Vicus Therapeutics, LLC, announced the initiation of a Phase 2 trial evaluating VT-122, a novel investigational combination of etodolac and propranolol, and Nexavar® (sorafenib) tablets, as a potential new treatment option for patients with advanced liver cancer (hepatocellular carcinoma)...
  8. T

    Biomet Announces Completion Of Clinical Trial Enrollment For Study Using The Recover

    Biomet, Inc., a global leader in the manufacture of orthopedic and biotechnology products, announced recently that its subsidiary, Biomet Biologics, LLC, has completed the required 230 subject enrollment for its Recover® Kit clinical trial. This clinical trial studies the use of the Recover®...
  9. T

    The ASCO Cancer Foundation(R) Announces Board Appointments For 2011

    The ASCO Cancer Foundation ® (TACF) announced the appointment and reappointment of members to its Board of Directors. Gabriel N. Hortobagyi, MD, FACP, a new appointee to the Board, will begin his three-year term on January 1, 2011. Terms for reappointed members Sandra M. Swain, MD, and John H...
  10. T

    Bionovo Announces Publication Describing Estrogen Receptor Beta Cancer Prevention Mec

    Bionovo, Inc. (Nasdaq: BNVI) announced the publication of a study demonstrating that ERb causes cancer cell growth arrest by inactivating critical genes and enzymes responsible for cell growth. These results provide evidence that drugs that stimulate the production of or activate ERb are...
  11. T

    Alkermes Announces Results From Phase 2 Study Of ALKS 33 In Alcohol Dependence

    Alkermes, Inc. (NASDAQ: ALKS) announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy...
  12. T

    China Cord Blood Corporation Announces Participation At The 29th Annual J.P. Morgan H

    China Cord Blood Corporation (NYSE: CO) ("CCBC" or "the Company"), the first and largest cord blood banking operator in China, announced that the Company will participate in the 29th Annual J.P. Morgan Healthcare Conference, to be held at the Westin St. Francis Hotel in San Francisco on January...
  13. T

    Bioheart Announces Plans To Advance LVAD + Muscle Stem Cells Clinical Trial

    Bioheart, Inc. (OTC Bulletin Board: BHRT) announced that at the American Heart Association Annual Meeting, it finalized the formation of a working group. The group's focus is to advance a BRIDGE TO RECOVERY clinical trial, combining a left ventricle assist device (LVAD) and Bioheart's MyoCell...
  14. T

    The Biomarkers Consortium Announces Availability Of Alzheimer's Disease Plasma Proteo

    The Foundation for the National Institutes of Health's Biomarkers Consortium announced that the results of a proteomics study performed utilizing plasma samples from the Alzheimer's Disease Neuroimaging Initiative (ADNI) are ready to be shared with scientists worldwide for further analysis...
  15. S

    iOrgsoft Announces Released PDF to Image Converter for Mac 2.0.1

    iOrgsoft Studio today brings to Mac users its compact and smart application, PDF to Image Converter for Mac, the PDF market's well welcome product. With its user-friendly interface and excellent features, the PDF to Image Converter for Mac delivers a vivid graphics and multi-options in...
  16. S

    iOrgsoft Announces Released PDF Converter for Mac 2.0.1-- iOrgsoft Studio release Mac

    iOrgsoft Studio today brings to Mac users its compact and smart application, PDF Converter for Mac, the PDF market's well welcome product. With its user-friendly interface and excellent features, the PDF Converter for Mac delivers a vivid graphics and multi-options in converting performance...
  17. T

    Sangart, Inc. Announces Cooperative Research And Development Agreement With The U.S.

    Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that it has entered into a...
  18. T

    Collegium Pharmaceutical Announces The Spin-Out Of Onset Therapeutics And The Launch

    Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has completed the spin-out of Onset Therapeutics, LLC, its wholly owned subsidiary focused on the Dermatology market. Onset will become part of PreCision Dermatology, Inc., a newly founded company that...
  19. T

    Dendreon Announces Presentation Of PROVENGE Data At The American Society Of Hematolog

    Dendreon Corporation (Nasdaq: DNDN) announced the following PROVENGE® (sipuleucel-T) data presentations taking place at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida and the Society of Urologic Oncology (SUO) Annual Meeting in Bethesda, Maryland. The following...
  20. T

    Ascension Orthopedics Announces Implantation Of The TITAN™ Modular Total Shoulder

    Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces another implantation of the TITAN™ Modular Total Shoulder. The surgery was performed by Matthew Ramsey, M.D. at Bucks County Specialty Hospital in Bensalem, Pennsylvania. "The surgery went well today and...
Back
Top